Fate Therapeutics’ development of programmed cell therapies is based on a simple notion: we believe that better cell therapies start with better cells. We are dedicated to bringing a first-in-class pipeline of off-the-shelf programmed cellular immunotherapies to patients with autoimmune diseases and cancer.
As part of this mission, we conduct clinical trials to study the safety and effectiveness of investigational therapies. We thank those who are helping us bring new treatments to patients by participating in our trials. We understand the decision to enroll in a clinical trial is a serious one, and we are committed to ensuring these trials are conducted with integrity and respect.